BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11822989)

  • 21. [Tumor angiogenesis inhibitors: media and scientific aspects].
    Raymond E
    Presse Med; 1998 Jul 4-11; 27(24):1221-4. PubMed ID: 9767782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiangiogenic agents in combination with chemotherapy for the treatment of epithelial ovarian cancer.
    Teoh D; Secord AA
    Int J Gynecol Cancer; 2012 Mar; 22(3):348-59. PubMed ID: 22266932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment.
    Hayes AJ; Li LY; Lippman ME
    BMJ; 1999 Mar; 318(7187):853-6. PubMed ID: 10092266
    [No Abstract]   [Full Text] [Related]  

  • 24. The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin.
    Dings RP; Yokoyama Y; Ramakrishnan S; Griffioen AW; Mayo KH
    Cancer Res; 2003 Jan; 63(2):382-5. PubMed ID: 12543791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antiangiogenic therapy].
    Toi M
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2003-9. PubMed ID: 9838900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Research on the endothelium and new therapeutic strategies in tumors and cardiovascular diseases].
    Dejana E
    Recenti Prog Med; 1999 Feb; 90(2):64-8. PubMed ID: 10208094
    [No Abstract]   [Full Text] [Related]  

  • 27. [Progress in the lung cancer therapy with angiogenesis inhibitors].
    Bai C; Ma T
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):306-7. PubMed ID: 11326959
    [No Abstract]   [Full Text] [Related]  

  • 28. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer.
    Reijerkerk A; Voest EE; Gebbink MF
    Eur J Cancer; 2000 Aug; 36(13 Spec No):1695-705. PubMed ID: 10959055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting angiogenesis in ovarian cancer.
    Schmitt J; Matei D
    Cancer Treat Rev; 2012 Jun; 38(4):272-83. PubMed ID: 21764518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted therapies for treatment of recurrent ovarian cancer.
    Grisham RN; Hyman DM; Iyer G
    Clin Adv Hematol Oncol; 2014 Mar; 12(3):158-62. PubMed ID: 24927263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular pathways of angiogenesis inhibition.
    Tabruyn SP; Griffioen AW
    Biochem Biophys Res Commun; 2007 Mar; 355(1):1-5. PubMed ID: 17276388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vascular growth and non-small cell lung cancer].
    Fan X; Guo X; Han B
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):499-502. PubMed ID: 11718044
    [No Abstract]   [Full Text] [Related]  

  • 34. Angiostatin and endostatin: endogenous inhibitors of tumor growth.
    Sim BK; MacDonald NJ; Gubish ER
    Cancer Metastasis Rev; 2000; 19(1-2):181-90. PubMed ID: 11191058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tumor angiogenesis].
    Ono M; Kuwano M
    Seikagaku; 1998 Sep; 70(9):1159-70. PubMed ID: 9796411
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy.
    Hahnfeldt P; Panigrahy D; Folkman J; Hlatky L
    Cancer Res; 1999 Oct; 59(19):4770-5. PubMed ID: 10519381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Angiogenesis and bladder cancer: trendy prognostic factor or new therapeutic target?].
    Jayet C; Deperthes D; Leisinger HJ
    Ann Urol (Paris); 2002 Jul; 36(4):258-63. PubMed ID: 12162191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenesis: a promising therapeutic target for ovarian cancer.
    Bamias A; Pignata S; Pujade-Lauraine E
    Crit Rev Oncol Hematol; 2012 Dec; 84(3):314-26. PubMed ID: 22575381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumor angiogenesis, and survival in platinum-treated patients.
    Alvarez AA; Axelrod JR; Whitaker RS; Isner PD; Bentley RC; Dodge RK; Rodriguez GC
    Gynecol Oncol; 2001 Aug; 82(2):273-8. PubMed ID: 11531279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis and antiangiogenic therapy.
    Sledge GW; Miller KD
    Curr Probl Cancer; 2002; 26(1):1-60. PubMed ID: 11961506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.